- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05641194
EaseAlert: Tactile Firefighter Alerting System
March 11, 2025 updated by: Joel Billings, Ph.D., Embry-Riddle Aeronautical University
EaseAlert: Tactile Firefighter Alerting System Designed to Reduce Negative Cardiovascular Outcomes and Sleep Disturbances
The purpose of this research is to test a commercially viable Fire Fighter Altering System (FFAS) comprised of proprietary wearables and optional bed shakers called BunkAlerts; collectively "personal alerting devices" as an alternative approach to the traditional fire alarm system used in fire stations.
Participants (fire fighters) will be asked to take part in the study to investigate the impact of the new FFAS on cardiovascular response and sleep.
This study includes three phases: 1) baseline, 2) implementation of EaseAlert FFAS with traditional alarm, and 3) implementation of EaseAlert FFAS without traditional alarm.
Participants will be asked to wear an Actigraph wGT3x-BT and Polar H10 device to record sleep and heart rate data for 12 days at work in addition to EaseAlert FFAS device for 8 out of the 12 days at work.
They will also be asked to complete a questionnaire and complete daily journal entries.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Sudden cardiac death (SCD) has been the leading cause of on-duty death (ODD) in the fire service over the past several decades, accounting for 51.6% of all ODDs in 2019.
The primary factors that contribute to SCD among firefighters are overexertion and stress, and SCD is most likely to occur during fire suppression and alarm response.
When an emergency occurs, firefighters are alerted/awoken by loud mechanical bells.
This high noise level may induce a stress response triggering a cardiovascular event.
In fact, "high levels of environmental noise fuel cardiac risk" by stimulating the amygdala and inflaming the arteries.
While other companies have attempted to modernize alerting systems, they failed to address the problem of stressful alarms because they focus on alerting "stations" not individual firefighters.
A significant need exists to develop a less stressful alerting system for firefighters.
The objective of this SBIR Phase I R43 research study is to develop a commercially viable Fire Fighter Alerting System (FFAS) comprised of proprietary wearables and optional bed shakers called BunkAlerts.
Collectively "personal alerting devices," the wearables and BunkAlerts enhance the alerting process for firefighters by replacing jarring audible alarms with tactile alerts delivered to the firefighter's wrist.
This alternative approach is designed to significantly decrease tachycardic responses associated with legacy alerting systems.
Meeting this need has the potential to reduce firefighter ODDs and improve the quality of life for the 15.4 million firefighters around the world.
The feasibility of EaseAlert's FFAS is reinforced by preliminary data collected during field testing with six (6) fire departments in three (3) states where EaseAlert's prototype FFAS ("Gen 1") successfully delivered over 10,000 alerts to firefighters called to an emergency with no calls missed.
The potential for the FFAS to reduce stress and SCD risk among firefighters is supported by preliminary data which shows that: 1) noise triggers a startle response and 2) tactile alerts are associated with positive valence and high arousal.
The proposed research will be accomplished with two aims: Aim 1 - develop a commercially viable FFAS and Aim 2 - determine the effectiveness of the FFAS in reducing cardiac reactivity and improving sleep.
EaseAlert will leverage the Gen 1 FFAS as a foundation for developing its Gen 2 FFAS outlined in Aim 1. Aim 2 will test two study hypotheses in a within-subjects pilot clinical trial design: (H2.1) that EaseAlert will result in a significant reduction in the stress response to alarms compared to traditional auditory alerting systems, and (H2.2) EaseAlert will result in a significant improvement in sleep efficiency.
Study Type
Interventional
Enrollment (Actual)
47
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Blue Springs, Missouri, United States, 64015
- Central Jackson County Fire District
-
-
Oklahoma
-
Stillwater, Oklahoma, United States, 74074
- Stillwater Fire Department
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
-
Participants must meet the following inclusion criteria:
- Firefighters must be willing participants be over the age of 18 years
- Have worked at their department for a minimum of two months (career department only) so that circadian rhythm is adjusted to the schedule
- No extended absence or shift trading among the firefighters foreseen during the trial.
- Nighttime call/run volume averaging at least one emergency call
- Interest among the crew members to participate in the trial
Inclusion criteria for departments will include, but not be limited to:
- Willingness to participate by department's chief and/or his/her designee
- No past experience with the EaseAlert FFAS
- Four or more firehouses/stations
- Willingness to identify a departmental point of contact for collaboration with the research team
- Interest among crews to test the new alert system.
Exclusion Criteria:
- non firefighter
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single arm - intervention
|
Description: Standard alerting system in place at the fire station.
Description: EaseAlert will activate and alert the subject of an emergency call without the legacy alerting system.
EaseAlert (standalone) replaces the legacy alerting system.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate (mean)
Time Frame: Change from baseline Heart Rate to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
Heart Rate will be measured with Polar H10 Heart Rate Chest Strap Monitor connected via Bluetooth to wGT3X-BT Actigraphy device.
Change from baseline Heart Rate to post interventions
|
Change from baseline Heart Rate to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
|
Heart Rate (max)
Time Frame: Change from baseline Heart Rate to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
Heart Rate will be measured with Polar H10 Heart Rate Chest Strap Monitor connected via Bluetooth to wGT3X-BT Actigraphy device.
Change from baseline Heart Rate to post interventions.
Max HR will factor subjects' age.
|
Change from baseline Heart Rate to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
|
Sleep Efficiency
Time Frame: Change from baseline to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
Sleep Efficiency will be measures by wrist actigraphy (device: wGT3X-BT).
Actilife 6.0 (issued by ActiGraph Co.) will be used to analyze actigraphy data.
Sleep Efficiency is calculated by dividing (total sleep time by total time in bed) X 100.
Change from baseline sleep efficiency to post interventions.
|
Change from baseline to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction with EaseAlert during Night
Time Frame: Change from baseline night satisfaction to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
Satisfaction with EaseAlert during the night will be assessed with a 10-point VAS Likert scale (lower scores indicate worse outcome) and an open ended option for additional thoughts.
Change from baseline night satisfaction to post interventions.
|
Change from baseline night satisfaction to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
|
Satisfaction with EaseAlert during Day
Time Frame: Change from baseline day satisfaction to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
Satisfaction with EaseAlert during the day will be assessed with a 10-point VAS Likert scale (lower scores indicate worse outcome) and an open ended option for additional thoughts.
Change from baseline day satisfaction to post interventions.
|
Change from baseline day satisfaction to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
|
Pre-bed anxiety/stress
Time Frame: Change from baseline pre-bed anxiety/stress to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
Pre-bed anxiety/stress will be assessed with a 10-point VAS Likert scale (higher scores indicate worse outcomes) prior to bed.
Change from baseline pre-bed anxiety/stress to post interventions.
|
Change from baseline pre-bed anxiety/stress to post interventions (6 days from baseline). Outcome will be assessed over 1 day per intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Joel M Billings, Ph.D., Embry-Riddle Aeronautical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 26, 2023
Primary Completion (Actual)
October 1, 2024
Study Completion (Actual)
January 31, 2025
Study Registration Dates
First Submitted
October 28, 2022
First Submitted That Met QC Criteria
November 29, 2022
First Posted (Actual)
December 7, 2022
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 11, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-131
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.